Research view
Switch to patient viewHigh blood pressure: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- AMPK 0
- SGLT2 3
- GLP-1 2
- PPAR 0
- AKT 0
- NLRP3 0
- PI3K 0
- NRF2 1
- HIF-1 0
- STAT3 0
- VEGF 0
- ACE2 0
- SIRT1 0
- TNF 1
- IL-6 1
- mTOR 0
- TLR4 0
- ERK 0
- MAPK 0
- HMGB1 0
- YAP 0
- CXCR4 0
- HSP90 0
- IL-17 1
- AR 1
- PCSK9 3
- APOE 1
- CD19 0
- GPX4 0
- JNK 0
- METTL3 0
- PINK1 0
- PTEN 0
- TP53 0
- ABL1 0
- APOL1 0
- BTK 2
- CD40 0
- FAK 0
- HDAC 0
- IL-1 0
- JAK 0
- MMP-9 0
- PKM2 0
- STK11 0
- CGRP 0
- CTNNB1 0
- DPP-4 0
- FTO 0
- RUNX1 0
- STING 0
- AXL 0
- CD38 0
- COX-2 0
- DMD 0
- GIP 0
- HTT 0
- IDH 0
- IGF1R 0
- MDM2 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-ERC
Selective Sensory Vagal Interface: a bionic platform for internal organ modulation (VisceraLink)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF
Birth and Labor Outcome Optimization through Multimodal AI (BLOOM)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Unveiling Dynamic Autonomic Regulation in health and disease through Network Physiology (DARNePh)
The disease is named only in the funder's project summary, not in the title.
5 of 51 running projects, newest first. Listed amounts together: €231.7m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 12
- Organoids 1
- Mendelian Randomization Analysis 85
- CRISPR-Cas Systems 2
- Gene Expression Profiling 52
- Sequence Analysis, RNA 5
- Whole Genome Sequencing 2
- Exome Sequencing 10
- Proteomics 45
- Metabolomics 45
- Mass Spectrometry 3
- Flow Cytometry 4
- Immunohistochemistry 24
- Liquid Biopsy 1
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 6
- Magnetic Resonance Imaging 123
- Machine Learning 101
- Deep Learning 13
- Cohort Studies 415
- Genome-Wide Association Study 82
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.